FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2967184466> ?p ?o ?g. }

• W2967184466 endingPage "e0217910" @default.
• W2967184466 startingPage "e0217910" @default.
• W2967184466 abstract "Substandard and falsified medications pose significant risks to global health. Nearly one in five antimalarials circulating in low- and middle-income countries are substandard or falsified. We assessed the health and economic impact of substandard and falsified antimalarials on children under five in Nigeria, where malaria is endemic and poor-quality medications are commonplace.We developed a dynamic agent-based SAFARI (Substandard and Falsified Antimalarial Research Impact) model to capture the impact of antimalarial use in Nigeria. The model simulated children with background characteristics, malaria infections, patient care-seeking, disease progression, treatment outcomes, and incurred costs. Using scenario analyses, we simulated the impact of substandard and falsified medicines, antimalarial resistance, as well as possible interventions to improve the quality of treatment, reduce stock-outs, and educate caregivers about antimalarial quality.We estimated that poor quality antimalarials are responsible for 12,300 deaths and $892 million ($890-$893 million) in costs annually in Nigeria. If antimalarial resistance develops, we simulated that current costs of malaria could increase by $839 million (11% increase, $837-$841 million). The northern regions of Nigeria have a greater burden as compared to the southern regions, with 9,700 deaths and $698 million ($697-$700 million) in total economic losses annually due to substandard and falsified antimalarials. Furthermore, our scenario analyses demonstrated that possible interventions-such as removing stock-outs in all facilities ($1.11 billion), having only ACTs available for treatment ($594 million), and 20% more patients seeking care ($469 million)-can save hundreds of millions in costs annually in Nigeria.The results highlight the significant health and economic burden of poor quality antimalarials in Nigeria, and the impact of potential interventions to counter them. In order to reduce the burden of malaria and prevent antimalarials from developing resistance, policymakers and donors must understand the problem and implement interventions to reduce the impact of ineffective and harmful antimalarials." @default.
• W2967184466 created "2019-08-22" @default.
• W2967184466 creator A5011933186 @default.
• W2967184466 creator A5018979549 @default.
• W2967184466 creator A5032063398 @default.
• W2967184466 creator A5035718195 @default.
• W2967184466 creator A5063549034 @default.
• W2967184466 creator A5074037928 @default.
• W2967184466 date "2019-08-15" @default.
• W2967184466 modified "2023-10-14" @default.
• W2967184466 title "The economic impact of substandard and falsified antimalarial medications in Nigeria" @default.
• W2967184466 cites W1275343739 @default.
• W2967184466 cites W1638473988 @default.
• W2967184466 cites W1823677338 @default.
• W2967184466 cites W1980793725 @default.
• W2967184466 cites W1982068379 @default.
• W2967184466 cites W2013218973 @default.
• W2967184466 cites W2031800071 @default.
• W2967184466 cites W2043585862 @default.
• W2967184466 cites W2043676704 @default.
• W2967184466 cites W2044381665 @default.
• W2967184466 cites W2049491497 @default.
• W2967184466 cites W2054167507 @default.
• W2967184466 cites W2063211167 @default.
• W2967184466 cites W2063236271 @default.
• W2967184466 cites W2071808888 @default.
• W2967184466 cites W2100536384 @default.
• W2967184466 cites W2103214555 @default.
• W2967184466 cites W2103572336 @default.
• W2967184466 cites W2106780373 @default.
• W2967184466 cites W2110137189 @default.
• W2967184466 cites W2110383454 @default.
• W2967184466 cites W2113170627 @default.
• W2967184466 cites W2113224665 @default.
• W2967184466 cites W2115877902 @default.
• W2967184466 cites W2128935603 @default.
• W2967184466 cites W2136945880 @default.
• W2967184466 cites W2138717517 @default.
• W2967184466 cites W2141398594 @default.
• W2967184466 cites W2142025416 @default.
• W2967184466 cites W2150488868 @default.
• W2967184466 cites W2151465389 @default.
• W2967184466 cites W2158111301 @default.
• W2967184466 cites W2161596395 @default.
• W2967184466 cites W2164791654 @default.
• W2967184466 cites W2165402727 @default.
• W2967184466 cites W2257388956 @default.
• W2967184466 cites W2554256565 @default.
• W2967184466 cites W2565054976 @default.
• W2967184466 cites W2886440016 @default.
• W2967184466 cites W2912083894 @default.
• W2967184466 cites W2914393772 @default.
• W2967184466 cites W2995323541 @default.
• W2967184466 cites W3125740660 @default.
• W2967184466 doi "https://doi.org/10.1371/journal.pone.0217910" @default.
• W2967184466 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6695148" @default.
• W2967184466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31415560" @default.
• W2967184466 hasPublicationYear "2019" @default.
• W2967184466 type Work @default.
• W2967184466 sameAs 2967184466 @default.
• W2967184466 citedByCount "43" @default.
• W2967184466 countsByYear W29671844662019 @default.
• W2967184466 countsByYear W29671844662020 @default.
• W2967184466 countsByYear W29671844662021 @default.
• W2967184466 countsByYear W29671844662022 @default.
• W2967184466 countsByYear W29671844662023 @default.
• W2967184466 crossrefType "journal-article" @default.
• W2967184466 hasAuthorship W2967184466A5011933186 @default.
• W2967184466 hasAuthorship W2967184466A5018979549 @default.
• W2967184466 hasAuthorship W2967184466A5032063398 @default.
• W2967184466 hasAuthorship W2967184466A5035718195 @default.
• W2967184466 hasAuthorship W2967184466A5063549034 @default.
• W2967184466 hasAuthorship W2967184466A5074037928 @default.
• W2967184466 hasBestOaLocation W29671844661 @default.
• W2967184466 hasConcept C118552586 @default.
• W2967184466 hasConcept C160735492 @default.
• W2967184466 hasConcept C162324750 @default.
• W2967184466 hasConcept C203014093 @default.
• W2967184466 hasConcept C27415008 @default.
• W2967184466 hasConcept C2778048844 @default.
• W2967184466 hasConcept C2780664029 @default.
• W2967184466 hasConcept C2908647359 @default.
• W2967184466 hasConcept C50522688 @default.
• W2967184466 hasConcept C71924100 @default.
• W2967184466 hasConcept C99454951 @default.
• W2967184466 hasConceptScore W2967184466C118552586 @default.
• W2967184466 hasConceptScore W2967184466C160735492 @default.
• W2967184466 hasConceptScore W2967184466C162324750 @default.
• W2967184466 hasConceptScore W2967184466C203014093 @default.
• W2967184466 hasConceptScore W2967184466C27415008 @default.
• W2967184466 hasConceptScore W2967184466C2778048844 @default.
• W2967184466 hasConceptScore W2967184466C2780664029 @default.
• W2967184466 hasConceptScore W2967184466C2908647359 @default.
• W2967184466 hasConceptScore W2967184466C50522688 @default.
• W2967184466 hasConceptScore W2967184466C71924100 @default.
• W2967184466 hasConceptScore W2967184466C99454951 @default.
• W2967184466 hasIssue "8" @default.
• W2967184466 hasLocation W29671844661 @default.

• next